PATENT CLAIM ANALYSIS

Application Number: 16118760
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["546", "119000"]

Abstract:
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Claim (Index 4):
The compound of  claim 1 , wherein R 1  is C 3 -C 6 -cycloalkyl or C 2 -C 5 -heterocyclyl, wherein cycloalkyl and heterocyclyl are optionally substituted with 1 or 2 groups each independently selected from \u2014OH, halo, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, \u2014O\u2014C 1 -C 6 -alkyl, and C 1 -C 6 -alkyl-OH.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.42308
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14984325', '15843598', '14984293', '15347468', '14984654']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.867437311414154
- 35 USC 102 Novelty (BERT): 0.6916758487161354
- Combined Prediction Score: 0.8498611651443522
- Mean Citation Score: 697.37725
- Max Citation Score: 724.7858
- Similarity Product: 716.0597539768578

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test